... San Antonio Breast Cancer Symposium 2023. The study results provide ... Disclosures: Some study authors declared affiliations with biotech, ...
News
- Pregnancy After Breast Cancer Treatment Is Not Contraindicated in BRCA Carriers
- Some breast cancer survivors may safely de-escalate mammography three years after surgery
Biomedical technology · Cardiology · Dentistry · Diabetes · Diseases ... San Antonio Breast Cancer Symposium, held December 5–9, 2023. Both U.S. ...
- Bluebird bio's sickle-cell disease treatment nets FDA approval - Boston Business Journal
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Biotech led by ex-Novartis exec brings in $90M for cancer drugs.
- Study Shows Positive Pregnancy Outcomes for BRCA1/2-Mutant Breast Cancer Patients
A recent study presented at the San Antonio Breast Cancer Symposium 2023 has revealed reassuring findings regarding pregnancy outcomes in patients ...
- How Houston can grow its biotech economy, according to experts - The Business Journals
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... That's made March Biosciences a rare bright spot in Houston's ...